COVID-19 Policy Update TUESDAY 10/13 TOP THREE Pfizer: The FDA granted approval to include children between the ages of 12 and 15. The inclusion could accelerate the deployment of a vaccine to children sooner than previously anticipated. Phase 4:
COVID-19 Policy Update #126
COVID-19 Policy Update #126
COVID-19 Policy Update #126
COVID-19 Policy Update TUESDAY 10/13 TOP THREE Pfizer: The FDA granted approval to include children between the ages of 12 and 15. The inclusion could accelerate the deployment of a vaccine to children sooner than previously anticipated. Phase 4: